RxDoctor Payments Data

James Galvin, MD

Behavioral Neurology & Neuropsychiatry · Boca Raton, FLNPI 1760408074

Payments from drug & device makers

$685,913in general payments, 2019–2025

Across 162 payments — averaging $4234.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$315K
  • Roche Diagnostics Operations, Inc.$100K
  • Eisai Inc.$82K
  • Novartis$70K
  • Roche Molecular Systems, Inc.$45K
  • Lilly USA, LLC$26K
  • plus $48K from 10 others
$44,611in research payments, 2019–2025

Across 3 payments — averaging $14,870 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$45K

What the payments were for

  • Consulting fees$279,62288%
  • Speaking & faculty fees$21,7407%
  • Travel & lodging$12,5424%
  • Food & beverage$2,7471%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few behavioral neurology & neuropsychiatry providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$16,640
Medicare patients
49
Services billed
97

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Donepezil Hcl29$407

Paid to pharmacies, not to this prescriber.

Other behavioral neurology & neuropsychiatry in Boca Raton

Where these figures come from

Is this you, or does something look wrong? →